Amgen (AMGN) Share-based Compensation Growth (5y) (2014 - 2023)

Amgen (AMGN) Share-based Compensation Growth (5y) (2014 - 2023) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2023 13.10%
Sep 30, 2023 6.20%
Jun 30, 2023 5.05%
Mar 31, 2023 -2.74%
Dec 31, 2018 -2.55%
Sep 30, 2018 -5.09%
Jun 30, 2018 -3.65%
Mar 31, 2018 -10.11%
Dec 31, 2017 -1.35%
Sep 30, 2017 -0.67%
Jun 30, 2017 -1.78%
Mar 31, 2017 -4.36%
Dec 31, 2016 -1.50%
Sep 30, 2016 3.17%
Jun 30, 2016 -2.15%
Mar 31, 2016 -7.55%
Dec 31, 2015 -5.29%
Sep 30, 2015 0.00%
Jun 30, 2015 -1.69%
Mar 31, 2015 0.58%